首页> 外国专利> Process for the preparation of a soluble antigenic material, or not Soluble in aqueous solutions or exogenous, comprising polysaccharides and / or glycopeptides (ASMP, anmp or AEMP)The antigenic material and its use, Vaccine and injection Solution on the basis of antigenic material, employing method

Process for the preparation of a soluble antigenic material, or not Soluble in aqueous solutions or exogenous, comprising polysaccharides and / or glycopeptides (ASMP, anmp or AEMP)The antigenic material and its use, Vaccine and injection Solution on the basis of antigenic material, employing method

机译:制备可溶性抗原物质或不溶于水溶液或外源性抗原物质的方法,包括多糖和/或糖肽(ASMP,anmp或AEMP)抗原物质及其用途,基于抗原物质的疫苗和注射液,采用方法

摘要

2.1.1.2. Procedures for preparing insoluble or insoluble antigen materials in aqueous or exogenous solutions, including multicapsular and / or sterile (ASMP, anmp or aemp),Interesting cells belonging to the corneal bacteria or yeast group or their own materials were used. The obtained antigen material has anti allergic effect in mammals. These materials contribute to the production of drugs for the treatment of death, as well as to the regulation of the immune response, vaccines and injection solutions. The candidate tissues (DSM n * 9656) and mutants of the Albian Episcopal Church are less pathological and provide these antigenic materials.
机译:2.1.1.2。使用在水性或外源性溶液中制备不溶性或不溶性抗原材料的程序,包括多囊和/或无菌(ASMP,amp或aemp),属于角膜细菌或酵母类的有趣细胞或它们自己的材料。所获得的抗原物质在哺乳动物中具有抗过敏作用。这些材料有助于生产用于治疗死亡的药物,以及调节免疫应答,疫苗和注射液。 Albian Episcopal Church的候选组织(DSM n * 9656)和突变体的病理学较少,可提供这些抗原性物质。

著录项

  • 公开/公告号AR008982A1

    专利类型

  • 公开/公告日2000-03-08

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM VETMEDICA GMBH;

    申请/专利号AR20100394896

  • 发明设计人

    申请日1996-08-12

  • 分类号C12P1/02;C07K14/37;A61K39/00;A61P37/08;

  • 国家 AR

  • 入库时间 2022-08-22 01:57:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号